![Bradley S. Galer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bradley S. Galer
Technik-/Wissenschafts-/F&E-Leiter bei Rapport Therapeutics, Inc.
Vermögen: 5 Mio $ am 30.06.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Stephen Farr | M | 65 |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | 18 Jahre |
Michael Patrick Smith | M | 55 |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | 7 Jahre |
David Bredt | M | 59 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 2 Jahre |
Iris Löw-Friedrich | M | 63 | 2 Jahre | |
Abraham Ceesay | M | 46 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 1 Jahre |
David Bredt | M | - |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 2 Jahre |
Steve Paul | M | - |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 2 Jahre |
James Healy | M | 59 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 1 Jahre |
Jeffrey Tong | M | 48 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | - |
Troy Ignelzi | M | 56 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 1 Jahre |
Reid Huber | M | 52 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 2 Jahre |
Arun Govindbhai Mistry | M | 58 |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | 9 Jahre |
Gavin Barker | M | 62 |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | 9 Jahre |
Cheryl Gault | F | 44 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 1 Jahre |
Terry-Ann Burrell | F | 47 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Thierry Darcis | M | - |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | 2 Jahre |
Roger L. Hawley | M | 71 | 13 Jahre | |
Joyce N. LaViscount | F | 62 |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 5 Jahre |
Ann Rhoads | F | 58 | 7 Jahre | |
James Breitmeyer | M | 70 | 16 Jahre | |
Arnold R. Gammaitoni | M | 56 | 10 Jahre | |
Ted H. Stanley | M | 83 | - | |
Denelle Waynick | F | 57 | 2 Jahre | |
Vickie Reed | F | 62 | - | |
Ashish M. Sagrolikar | M | 57 | 4 Jahre | |
Mary-Jane Burkett | F | - | - | |
Shawnte Mitchell | F | 46 | - | |
Steven A. Johnson | M | - | 11 Jahre | |
Erle T. Mast | M | 61 | 14 Jahre | |
Renee Tannenbaum | M | 72 | 7 Jahre | |
Edward F. Smith | M | 70 | 9 Jahre | |
Mary E. Stutts | F | 68 | 2 Jahre | |
Roland Gerritsen van der Hoop | M | - |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | - |
Caroline Loewy | F | 58 | 2 Jahre | |
Louis C. Bock | M | 59 | 16 Jahre | |
James Blair | M | 84 | 8 Jahre | |
Mark Wiggins | M | 68 | 11 Jahre | |
Sherri Leonard | F | - |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 2 Jahre |
Melinda Baker | F | - | 3 Jahre | |
Raymond Kelleher | M | 59 |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | 1 Jahre |
Jennifer Trevett | F | - | - | |
Thiyagaraja Ravindran | M | - | - | |
Thomas Doyle | M | 53 | 8 Jahre | |
Veronica Cai | F | 48 | 2 Jahre | |
Alexander David Robert Williams | M | - |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | - |
Stephen J. Andrzejewski | M | 58 |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | - |
Phillip Schwartz | M | 61 |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 5 Jahre |
Alex Arfaei | M | - |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 2 Jahre |
Gail Farfel | M | 60 | 7 Jahre | |
John Buckingham | M | - |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 4 Jahre |
Eric J. Vandal | M | - | - | |
James L. Moulds | M | - | 6 Jahre | |
Scott R. Shively | M | 67 | 2 Jahre | |
Edward J. Sweeney | M | 54 |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 7 Jahre |
Jeremy Goldberg | M | - |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 48 | 87,27% |
Vereinigtes Königreich | 6 | 10,91% |
Kanada | 5 | 9,09% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Bradley S. Galer
- Persönliches Netzwerk